Current and future immune approaches in precision medicine

Precision medicine enabled histology agnostic development of immunotherapeutics

Incorporating liquid biopsies into clinical trials

DNA damage response inhibition

Big data, scientific wellness and transforming healthcare

Bayesian adaptive trial designs for precision medicine

Redesigning clinical trials in the era of precision medicine

Genomic-driven clinical studies in breast cancer

Genomic predictors of treatment response in prostate cancer

Synthetic lethality as a basis to select drug combinations

Genomic analysis of childhood tumours; biological and therapeutic implications

Patient-specific peptide vaccines